Message from UW ICTR Leadership about our COVID-19 response

A recurring series of posts from our leadership and faculty directors:

We are all living through dangerous and challenging times due to the global COVID-19 pandemic. ICTR staff and leadership promptly adopted federal, state, and organizational recommendations and began aggressive social distancing measures over three weeks ago for the safety of our co-workers and the broader public. At this time, all non-essential ICTR staff are working from home and our physical offices are closed.

Despite this distancing, ICTR is putting our resources to work to directly support investigators who are pivoting their clinical research expertise to develop new treatments and therapeutics against COVID-19. For example, the ICTR community is working hard to advance:

  • Interventional trials to determine effective COVID-19 treatments
  • Joint pilot funding initiatives with the Wisconsin Partnership Program to ensure health equity related to COVID-19 responses
  • A new clearinghouse website providing updates about the conduct of clinical research during the COVID-19 pandemic
  • A COVID-19 shared data repository to use informatics and machine learning to support clinical research into unanticipated patterns of disease risk and best practices
  • Reallocation of resources and personnel to address urgent needs in the fight against COVID-19

We also continue to work diligently on activities related to our core mission of advancing the conduct of clinical and translational research at UW-Madison. Just this week:

Feel free to continue contacting staff by email or through our consult forms.

Stay safe and healthy. We’re all in this together!

~Allan and Beth~

Elizabeth BurnsideAllan Brasier, MD, is ICTR Executive Director, as well as  SMPH Senior Associate Dean for Clinical & Translational Research. Elizabeth Burnside, MD, MPH, ICTR Deputy Executive Director, is also SMPH Associate Dean for Team Science & Interdisciplinary Research.